The MET Oncogene as a Therapeutical Target in Cancer Invasive Growth

Abstract

The MET proto-oncogene, encoding the tyrosine kinase receptor for Hepatocyte Growth Factor (HGF) regulates invasive growth, a genetic program that associates control of cell proliferation with invasion of the extracellular matrix and protection from apoptosis. Physiologically, invasive growth takes place during embryonic development, and, in post-natal life… (More)
DOI: 10.3389/fphar.2012.00164

Topics

1 Figure or Table

Cite this paper

@inproceedings{Luraghi2012TheMO, title={The MET Oncogene as a Therapeutical Target in Cancer Invasive Growth}, author={Paolo Luraghi and Florian Schelter and Achim Kr{\"u}ger and Carla Boccaccio}, booktitle={Front. Pharmacol.}, year={2012} }